Titre : Facteurs chimiotactiques

Facteurs chimiotactiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cross Infection
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteurs chimiotactiques : Questions médicales les plus fréquentes", "headline": "Facteurs chimiotactiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteurs chimiotactiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-28", "dateModified": "2026-01-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteurs chimiotactiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteurs biologiques", "url": "https://questionsmedicales.fr/mesh/D001685", "about": { "@type": "MedicalCondition", "name": "Facteurs biologiques", "code": { "@type": "MedicalCode", "code": "D001685", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Facteurs chimiotactiques des éosinophiles", "alternateName": "Chemotactic Factors, Eosinophil", "url": "https://questionsmedicales.fr/mesh/D002631", "about": { "@type": "MedicalCondition", "name": "Facteurs chimiotactiques des éosinophiles", "code": { "@type": "MedicalCode", "code": "D002631", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.125.320" } } }, { "@type": "MedicalWebPage", "name": "N-Formyl-méthionyl-leucyl-phénylalanine", "alternateName": "N-Formylmethionine Leucyl-Phenylalanine", "url": "https://questionsmedicales.fr/mesh/D009240", "about": { "@type": "MedicalCondition", "name": "N-Formyl-méthionyl-leucyl-phénylalanine", "code": { "@type": "MedicalCode", "code": "D009240", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.125.685" } } } ], "about": { "@type": "MedicalCondition", "name": "Facteurs chimiotactiques", "alternateName": "Chemotactic Factors", "code": { "@type": "MedicalCode", "code": "D002630", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chun Mao", "url": "https://questionsmedicales.fr/author/Chun%20Mao", "affiliation": { "@type": "Organization", "name": "National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, China." } }, { "@type": "Person", "name": "Mimi Wan", "url": "https://questionsmedicales.fr/author/Mimi%20Wan", "affiliation": { "@type": "Organization", "name": "National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, China." } }, { "@type": "Person", "name": "Sujit S Datta", "url": "https://questionsmedicales.fr/author/Sujit%20S%20Datta", "affiliation": { "@type": "Organization", "name": "Chemical and Biological Engineering, Princeton University, Princeton, New Jersey. Electronic address: ssdatta@princeton.edu." } }, { "@type": "Person", "name": "Ting Li", "url": "https://questionsmedicales.fr/author/Ting%20Li", "affiliation": { "@type": "Organization", "name": "National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China." } }, { "@type": "Person", "name": "Chi Zhang", "url": "https://questionsmedicales.fr/author/Chi%20Zhang", "affiliation": { "@type": "Organization", "name": "Hefei National Laboratory for Physical Sciences at the Microscale and Department of Physics, University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of Infection Prevention Programs on Catheter-Associated Urinary Tract Infections Analyzed in Multicenter Study.", "datePublished": "2024-05-13", "url": "https://questionsmedicales.fr/article/38742291", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2024.39.e151" } }, { "@type": "ScholarlyArticle", "name": "Acinetobacter Metabolism in Infection and Antimicrobial Resistance.", "datePublished": "2023-05-16", "url": "https://questionsmedicales.fr/article/37191522", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/iai.00433-22" } }, { "@type": "ScholarlyArticle", "name": "ABO blood groups and nosocomial infection.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37009679", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/S0950268823000432" } }, { "@type": "ScholarlyArticle", "name": "Disparities in central line-associated bloodstream infection and catheter-associated urinary tract infection rates: An exploratory analysis.", "datePublished": "2023-04-14", "url": "https://questionsmedicales.fr/article/37057848", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/ice.2023.63" } }, { "@type": "ScholarlyArticle", "name": "Uses of a real-time automatic nosocomial infection surveillance system to support prevention and control of hospital-acquired infections in the ICU.", "datePublished": "2024-09-13", "url": "https://questionsmedicales.fr/article/39346583", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1399067" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Facteurs chimiotactiques", "item": "https://questionsmedicales.fr/mesh/D002630" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteurs chimiotactiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteurs chimiotactiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteurs chimiotactiques", "description": "Comment diagnostiquer une réponse chimiotactique ?\nQuels tests sont utilisés pour évaluer les facteurs chimiotactiques ?\nLes facteurs chimiotactiques sont-ils mesurables ?\nQuels marqueurs indiquent une chimiotaxie active ?\nPeut-on détecter des facteurs chimiotactiques dans les infections ?", "url": "https://questionsmedicales.fr/mesh/D002630?mesh_terms=Cross+Infection&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteurs chimiotactiques", "description": "Quels symptômes indiquent une chimiotaxie ?\nLa douleur est-elle liée aux facteurs chimiotactiques ?\nLes facteurs chimiotactiques causent-ils de la fièvre ?\nQuels signes cliniques sont associés à la chimiotaxie ?\nLes facteurs chimiotactiques affectent-ils la fatigue ?", "url": "https://questionsmedicales.fr/mesh/D002630?mesh_terms=Cross+Infection&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteurs chimiotactiques", "description": "Comment prévenir une réponse chimiotactique ?\nLes vaccins influencent-ils la chimiotaxie ?\nUne alimentation saine aide-t-elle à prévenir la chimiotaxie ?\nLe stress affecte-t-il la chimiotaxie ?\nL'exercice régulier aide-t-il à prévenir la chimiotaxie ?", "url": "https://questionsmedicales.fr/mesh/D002630?mesh_terms=Cross+Infection&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteurs chimiotactiques", "description": "Comment traiter une réponse chimiotactique excessive ?\nLes antibiotiques influencent-ils la chimiotaxie ?\nY a-t-il des traitements ciblant les facteurs chimiotactiques ?\nLes traitements immunomodulateurs affectent-ils la chimiotaxie ?\nLa physiothérapie aide-t-elle en cas de chimiotaxie ?", "url": "https://questionsmedicales.fr/mesh/D002630?mesh_terms=Cross+Infection&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteurs chimiotactiques", "description": "Quelles complications peuvent résulter d'une chimiotaxie excessive ?\nLa chimiotaxie peut-elle causer des infections ?\nQuels risques sont associés à une chimiotaxie prolongée ?\nLes complications cardiovasculaires sont-elles liées à la chimiotaxie ?\nLa chimiotaxie affecte-t-elle la guérison des plaies ?", "url": "https://questionsmedicales.fr/mesh/D002630?mesh_terms=Cross+Infection&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteurs chimiotactiques", "description": "Quels facteurs augmentent le risque de chimiotaxie ?\nL'âge influence-t-il la chimiotaxie ?\nLe tabagisme affecte-t-il la chimiotaxie ?\nLes maladies auto-immunes augmentent-elles le risque de chimiotaxie ?\nLe surpoids influence-t-il la chimiotaxie ?", "url": "https://questionsmedicales.fr/mesh/D002630?mesh_terms=Cross+Infection&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une réponse chimiotactique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse des cellules immunitaires dans le sang et les tissus peut indiquer une chimiotaxie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les facteurs chimiotactiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des biopsies peuvent être effectués pour mesurer les facteurs chimiotactiques." } }, { "@type": "Question", "name": "Les facteurs chimiotactiques sont-ils mesurables ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être quantifiés par des techniques comme l'immunoessai." } }, { "@type": "Question", "name": "Quels marqueurs indiquent une chimiotaxie active ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de cytokines comme IL-8 peuvent indiquer une chimiotaxie active." } }, { "@type": "Question", "name": "Peut-on détecter des facteurs chimiotactiques dans les infections ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections provoquent souvent une augmentation des facteurs chimiotactiques." } }, { "@type": "Question", "name": "Quels symptômes indiquent une chimiotaxie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur et gonflement au site d'inflammation sont des symptômes courants." } }, { "@type": "Question", "name": "La douleur est-elle liée aux facteurs chimiotactiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inflammation causée par la chimiotaxie peut entraîner des douleurs." } }, { "@type": "Question", "name": "Les facteurs chimiotactiques causent-ils de la fièvre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent contribuer à la fièvre en stimulant la réponse immunitaire." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à la chimiotaxie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent œdème, érythème et douleur au site d'infection." } }, { "@type": "Question", "name": "Les facteurs chimiotactiques affectent-ils la fatigue ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inflammation peut provoquer une fatigue générale due à la réponse immunitaire." } }, { "@type": "Question", "name": "Comment prévenir une réponse chimiotactique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter les infections peut réduire la chimiotaxie." } }, { "@type": "Question", "name": "Les vaccins influencent-ils la chimiotaxie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins peuvent préparer le système immunitaire et réduire les réponses inflammatoires." } }, { "@type": "Question", "name": "Une alimentation saine aide-t-elle à prévenir la chimiotaxie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut renforcer le système immunitaire et réduire l'inflammation." } }, { "@type": "Question", "name": "Le stress affecte-t-il la chimiotaxie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut altérer la réponse immunitaire et augmenter l'inflammation." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir la chimiotaxie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la circulation et réduire l'inflammation." } }, { "@type": "Question", "name": "Comment traiter une réponse chimiotactique excessive ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des anti-inflammatoires et des corticostéroïdes peuvent être utilisés pour réduire l'inflammation." } }, { "@type": "Question", "name": "Les antibiotiques influencent-ils la chimiotaxie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation en éliminant les agents pathogènes." } }, { "@type": "Question", "name": "Y a-t-il des traitements ciblant les facteurs chimiotactiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies biologiques ciblant des cytokines spécifiques sont en développement." } }, { "@type": "Question", "name": "Les traitements immunomodulateurs affectent-ils la chimiotaxie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent moduler la réponse immunitaire et influencer la chimiotaxie." } }, { "@type": "Question", "name": "La physiothérapie aide-t-elle en cas de chimiotaxie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut réduire la douleur et améliorer la circulation au site d'inflammation." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'une chimiotaxie excessive ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une inflammation chronique peut entraîner des maladies auto-immunes ou des lésions tissulaires." } }, { "@type": "Question", "name": "La chimiotaxie peut-elle causer des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une réponse immunitaire inappropriée peut favoriser des infections secondaires." } }, { "@type": "Question", "name": "Quels risques sont associés à une chimiotaxie prolongée ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une chimiotaxie prolongée peut entraîner des dommages tissulaires et des cicatrices." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles liées à la chimiotaxie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inflammation chronique peut augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "La chimiotaxie affecte-t-elle la guérison des plaies ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une réponse inflammatoire excessive peut retarder la guérison des plaies." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de chimiotaxie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les infections, le stress et les maladies chroniques augmentent le risque de chimiotaxie." } }, { "@type": "Question", "name": "L'âge influence-t-il la chimiotaxie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir une réponse inflammatoire plus forte." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la chimiotaxie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut exacerber l'inflammation et la réponse immunitaire." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque de chimiotaxie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer une réponse inflammatoire accrue et une chimiotaxie." } }, { "@type": "Question", "name": "Le surpoids influence-t-il la chimiotaxie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est associée à une inflammation chronique et à une chimiotaxie accrue." } } ] } ] }

Sources (10000 au total)

Impact of Infection Prevention Programs on Catheter-Associated Urinary Tract Infections Analyzed in Multicenter Study.

Catheter-associated urinary tract infections (CAUTIs) account for a large proportion of healthcare-associated infections and have a significant impact on morbidity, length of hospital stay, and mortal... Intervention programs, including training, surveillance, and monitoring, were implemented. Data on the microorganisms responsible for CAUTIs, urinary catheter utilization ratio, rate of CAUTIs per 1,0... Thirty-two hospitals participated in the study, including 21 university hospitals and 11 small- and medium-sized hospitals. The microorganisms responsible for CAUTIs and their resistance rates did not... We implemented interventions to prevent CAUTIs and evaluated their outcomes. The incidence of these infections decreased in the initial phases of the intervention when adequate support and personnel w...

Uses of a real-time automatic nosocomial infection surveillance system to support prevention and control of hospital-acquired infections in the ICU.

The intensive care unit (ICU) caters to patients with severe illnesses or injuries who require constant medical attention. These patients are susceptible to infections due to their weak immune systems... A retrospective analysis was conducted using data from an RT-NISS for all inpatients in the ICU from January 2021 to December 2022. Univariate and multivariate logistic regression analyses were perfor... The relative risk factors, observed as being a significantly higher risk of developing HAI, were hospitalization over 2 weeks, chronic lung diseases, chronic heart diseases, chronic renal diseases, cu... The adoption of an RT-NISS can adequately and accurately collect HAI case information to analyse the relative high-risk factors for developing HAIs in the ICU. Furthermore, implementing comprehensive ...

Most hospital patients at risk for bacterial infection undergo an anesthetic: implications for infection control practices related to the anesthesia workspace.

Even with nearly 100% compliance with prophylactic antibiotic protocols, many surgical patients (> 5%) develop surgical site infections, some caused by pathogens transmitted from the anesthesia worksp... We conducted a retrospective cohort study which included every patient admitted to the University of Miami Health System from April 2021 through March 2022 for hospitalization, surgery, emergency depa... Among 28,213 patient encounters including parenteral antibiotic(s), more than half (64.3%) also included an anesthetic (99% confidence interval, 62.2 to 66.6). The hypothesis that most antibiotics wer... Because approximately two-thirds of patients who receive an intravenous antibiotic also undergo an anesthetic, greater use of effective infection control measures in the anesthesia operating room work...

Tuberculosis infection prevention and control in rural Papua New Guinea: an evaluation using the infection prevention and control assessment framework.

Papua New Guinea (PNG) is one of the 14 countries categorised as having a triple burden of tuberculosis (TB), multidrug-resistant TB (MDR TB), and TB-human immunodeficiency virus (HIV) co-infections. ... The implementation of TB-IPC policy was assessed using a survey method based on the World Health Organization (WHO) IPC assessment framework (IPCAF) to implement the WHO's IPC core components. The stu... Overall, implementation of IPC and TB-IPC guidelines was inadequate in participating facilities. Though 80% of facilities had an IPC program, many needed more clearly defined IPC objectives, budget al... The WHO-recommended TB-IPC policy is not effectively implemented in most of the participating district hospitals. Improvements in implementing and disseminating TB-IPC guidelines, monitoring TB-IPC pr...

Evaluation of hospital-onset bloodstream infections compared to central line...associated bloodstream infections at an acute, tertiary care hospital.

Central line...associated bloodstream infection (CLABSI) is the current benchmark used in HAI (Hospital-associated infection) surveillance and effective interventions have greatly reduced the incidenc... Utilizing electronic medical charts, we determined if each blood culture met the HOBSI criteria according to the National Health care and Safety Network LabID and BSI definitions. We calculated the in... The IR of HOBSI using the LabID definition was 10.25. Using the BSI definition, we found an IR of 3.77. The IR of CLABSI for the same period was 1.84.... After excluding secondary BSIs, the HOBSI rate is still double that of the CLABSI rate. HOBSI surveillance is a more sensitive indicator of BSI than CLABSI, and thus a better target for monitoring eff...

Infections after musculoskeletal injuries in earthquake survivors.

This study aimed to investigate the infections following musculoskeletal injuries in earthquake survivors, offering a future clinical point of reference for the handling of musculoskeletal injuries re... In this single-center retrospective observational study, 225 earthquake survivors (120 females, 105 males; median: 39 years; range, 18 to 94 years) admitted between February 2023 and April 2023 were e... Among all cultures, the most isolated pathogen was Acinetobacter baumannii (49.4%), followed by enterococci (28.6%). Colistin sensitivity of A. baumannii was 36 (94.7%). However, sensitivity rate was ... While gram-positive microorganisms are frequently the causative microorganisms in infections after traumatic injuries, this study revealed that gram-negative microorganisms could be observed more freq...